The Surprise Question as a Trigger for Primary Palliative Care Interventions for Children with Advanced Heart Disease

Faraz Alizadeh1,2, Emily Morell3,4, Kevin Hummel5,6

  • 1Department of Cardiology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA. Faraz.Alizadeh@cardio.chboston.org.

Insights

The surprise question accurately predicts one-year mortality in children with advanced heart disease (AHD). This tool helps identify high-risk pediatric patients for palliative care and advance care planning.

Area of Science:

  • Pediatric Cardiology
  • Palliative Care
  • Clinical Prognostics

Background:

  • Prognosis in pediatric advanced heart disease (AHD) is uncertain.
  • Lack of reliable entry criteria for palliative care studies in AHD.
  • Need for tools to identify high-risk pediatric patients.

Purpose of the Study:

  • Evaluate the "surprise question" to predict one-year mortality in AHD.
  • Assess the surprise question's utility as entry criteria for clinical trials.
  • Identify children with AHD at high risk for mortality.

Main Methods:

  • Prospective cohort study of physicians and nurses caring for children (1 month-19 years) with AHD.
  • Physicians asked: "Would you be surprised if this child died within the next year?"
  • Medical record review and one-year mortality follow-up.

Main Results:

  • "No surprise" response predicted one-year mortality with 77% sensitivity and 73% specificity.
  • Patients with a "No" response had a 7.25-fold increased 1-year risk of death (p < 0.001).
  • Physician experience/competency did not impact accuracy.

Conclusions:

  • The surprise question is a promising bedside tool for identifying children with AHD at high risk of mortality.
  • Facilitates palliative care and advance care planning discussions.
  • Potential to serve as a reliable entry criterion for future AHD trials.

Related Concept Videos

Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
150
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.6K
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
55
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
73
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
43
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
42